Search / Trial NCT06230315

Visual Examination of Airway Via Flexible Fiberoptic Scope After Cervical Spine Surgery

Launched by STATE UNIVERSITY OF NEW YORK - UPSTATE MEDICAL UNIVERSITY · Jan 18, 2024

Trial Information

Current as of December 30, 2024

Completed

Keywords

Leak Test Cervical Spine Surgery

ClinConnect Summary

Because direct visualization of the airway is the most reliable way for the diagnosing and assessing the degree of laryngeal and trachea edema or swelling, investigators sought to do a study to evaluate the degree of airway edema in adult patients undergoing for CSS using direct visualization via flexible fiberoptic and compare the results pre and post- operatively.

The primary outcome will be severity of larynx and trachea edema after cervical spine surgery.

Secondary outcome will be assessment of reliability of airway leak technique and association between face swelling and airway edema...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Adult patient age 18-70 years.
  • 2. Elective cervical spine surgeries involving in upper CSS, ≥ 2 levels, surgical duration ≥ 2 hours
  • 3. ASA class \<4
  • Exclusion Criteria:
  • 1. RSI (rapid-sequence induction) and patients with high aspiration risk (postpartum).
  • 2. Emergency surgery
  • 3. Angioedema
  • 4. History of airway malignancy.
  • 5. Recent upper airway surgery.
  • 6. Significant recent upper airway infection or abscess.
  • 7. History of radiation therapy
  • 8. Nasogastric tube in place.
  • 9. Tracheostomy in place.
  • 10. History of basal skull fracture or extensive maxillofacial fracture.
  • 11. Severe nasal septum deviation.
  • 12. Morbid obesity BMI \> 40.
  • 13. Surgery involves in C1.
  • 14. History of epistaxis or bleeding disorder

Trial Officials

Luay Nubani, MBCHB

Principal Investigator

State University of New York - Upstate Medical University

About State University Of New York Upstate Medical University

The State University of New York - Upstate Medical University is a premier academic institution dedicated to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, Upstate Medical University focuses on translating scientific discoveries into effective medical treatments and improving patient outcomes. With a commitment to excellence in clinical research, the university collaborates with multidisciplinary teams to conduct studies that address critical health challenges, ensuring rigorous methodologies and adherence to ethical standards. Through its robust infrastructure and expertise, Upstate Medical University plays a vital role in shaping the future of medicine and enhancing community health.

Locations

Syracuse, New York, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0